One of Janet Woodcock’s lessons learned from the coronavirus pandemic was that a simple clinical trial to test repurposed medications was necessary earlier to answer questions that are still lingering one year later.
Woodcock, the US Food and Drug Administration’s acting commissioner, said that she wished that while working on therapeutic development for...







